Morphine Completed Phase 3 Trials for Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01309386A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants